Over 90 Total Lots Up For Auction at One Location - WA 04/08

Representatives From Biomet and Conceptus Elected to MDMA Board During Annual Meeting

by Barbara Kram, Editor | June 05, 2007
New leadership for the
medical technology industry

(click to enlarge)
Washington, D.C. -- The Medical Device Manufacturers Association (MDMA) recently welcomed to its Board of Directors, Mark M. Sieczkarek, President and CEO of Conceptus, Inc. in Mountain View, CA and Wil C. Boren IV, Corporate Vice President and Officer of Biomet, Inc. in Warsaw, IN.

"It is a privilege to serve on the MDMA Board of Directors and represent the interests of the medical technology industry," Sieczkarek said. "MDMA focuses on the key issues that impact innovative, entrepreneurial medical technology companies and I look forward to being an active contributor."

"It is an honor to be elected by the Membership and serve on the MDMA Board," Boren said. "I have been an active Member in MDMA and have been very impressed with the success the organization has had on critical issues impacting patient care and innovation. I look forward to continuing my work on behalf of the MDMA Membership."

"We are pleased to welcome Mark Sieczkarek and Wil Boren to the MDMA Board. Both have extensive knowledge and experience dealing with critical issues impacting the medical technology industry. Their leadership and insights will serve the MDMA Board and Membership well," said Mark Leahey, Executive Director of MDMA.

At a meeting of the Board of Directors on May 18th, Joe Kiani, Chairman and CEO of Masimo Corporation was elected Chairman for a two year term. The board also elected Eamonn Hobbs, President and CEO of AngioDynamics, as Vice Chair, Kelvyn Cullimore Jr., President and CEO of Dynatronics, as Secretary and Alex Lukianov, Chairman and CEO of Nuvasive, as Treasurer.

"I look forward to serving as Chairman of the MDMA Board of Directors and building on the success MDMA has enjoyed over the past fifteen years," Kiani said. "Today medical technology companies must deal with a series of critical issues that are being debated in Washington and have a direct impact on its ability to succeed in the market. As Chairman, I will work to ensure that MDMA continues to take a leadership role in representing the interests of innovative, entrepreneurial companies in Washington."